Why not to use erythromycin in GI motility [1] (multiple letters)

Chest

Volumn 121, Issue 1, 2002, Pages 301-302

  Guerin, Jean Michael ^a   Leibinger, F ^a   Mutlu, Gökhan M ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; ERYTHROMYCIN; MACROLIDE; METOCLOPRAMIDE; PROKINETIC AGENT; PRUCALOPRIDE; SEROTONIN 4 AGONIST;

ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; DRUG EFFICACY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HOSPITAL INFECTION; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0036157664     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.1.301     Document Type: Letter

References (3)

1. GM Mutlu EA Mutlu P Factor GI complications in patients receiving mechanical ventilation Chest 2001 1222 1241
2. American Thoracic Society Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies; a consensus statement Am J Respir Crit Care Med 153 1995 1711 1725
3. K Gay W Baughan J Miller The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment J Infect Dis 182 2000 1417 1424